ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases
Dec 04
2023
ÎÚÑ»´«Ã½. (2023).
ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases.
Retrieved from /advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases.
ÎÚÑ»´«Ã½.
"ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases." Hematology.org.
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases
(label-accessed November 18, 2024).
"ÎÚÑ»´«Ã½."
ASH Letter to FDA re Draft Guidance on Graft versus Host Diseases, 18 Nov. 2024 ,
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-graft-versus-host-diseases.
